TSXV:NSP.H - Post by User
Post by
dontknowmuchon May 21, 2020 11:15am
338 Views
Post# 31056222
NSP teams with Biologic Pharmamedical-Phase 2 clinical study
NSP teams with Biologic Pharmamedical-Phase 2 clinical study Naturally Splendid teams with Biologic Pharmamedical for a Phase 2 clinical study Naturally Splendid (CVE: NSP- OTC: NSPDF) CEO Craig Goodwin and Biologic Pharmamedical CEO Franco Cavaleri joined Steve Darling from Proactive Vancouver to share details the two companies have formed a joint venture for the purpose of further developing and pursuing phase 2 clinical studies, utilizing one of Biologic's patented technologies as a candidate for a potential COVID 19 treatment. Goodwin discusses the joint venture while Cavaleri shares the details about the study what the timing will look like.
Link to video 10:28 long
***** Be safe! *****
“Living in the sunshine” Always DYODD DKM